Previous 10 | Next 10 |
CINCINNATI, Nov. 05, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, as well as other indications in which the C...
Should These Be On Your Watch List Right Now? When it comes to penny stocks , the extended hours can be some of the most important. Trading is limited depending on your account, however, it’s not completely shut off. What that means is that there’s a chance to identify...
The first participant has been dosed in a 180-subject Phase 2 clinical trial, RESCUE, evaluating Aerpio Pharmaceuticals' (ARPO) Tie 2 activator razuprotafib in patients with moderate-to-severe COVID-19.The primary endpoint of the U.S. military-sponsored trial is safety. Secondary endpoints in...
The trial in moderate-to-severe patients is Aerpio’s second clinical trial in COVID-19 patients and is funded in part by the U . S . military The military - sponsored trial is complementary to the previously announced I - SPY CO...
Are These Penny Stocks To Buy Or Sell After The Latest Market Moves? Looking for penny stocks to buy can become a needle in a haystack. On the other hand, there might be so many options to choose from, it’s difficult to narrow things down. Obviously to opposite ends of the sp...
Gainers: JinkoSolar Holding (JKS) +18%.HireQuest (HQI) +16%.American Well (AMWL) +16%.Hilltop Holdings (HTH) +13%.Daqo New Energy (DQ) +12%.Perion Network (PERI) +12%.Qutoutiao (QTT) +11%.Entercom Communications (ETM) +10%.Aerpio Pharmaceuticals (ARPO) +9%.Annexon (ANNX) +8%.Lo...
HOUSTON, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Aravive, Inc. (Nasdaq: ARAV), a clinical-stage biopharmaceutical company developing transformative therapeutics, today announced that Michael W. Rogers joined the Company’s Board of Directors. Mr. Rogers is a biopharmaceutical vet...
Aerpio Pharmaceuticals (NASDAQ: ARPO ) announces the completion of enrollment in a 195-subject Phase 2 study assessing razuprotafib in patients elevated intraocular pressure (IOP) associated with open angle glaucoma or ocular hypertension. More news on: Aerpio Pharmaceuticals...
The first patient has been dos ed in a 1,500-subject Phase 2 platform study, I-SPY COVID , evaluating repurposed and investigational drugs in critically ill COVID-19 patients. More news on: Gilead Sciences, Inc., AbbVie Inc., Takeda Pharmaceutical Company Limited, Healthcare stocks news,...
SAN FRANCISCO and CINCINNATI, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Aerpio Pharmaceuticals, Inc. ("Aerpio") (Nasdaq: ARPO) and Quantum Leap Healthcare Collaborative™ (Quantum Leap) announced today dosing of the first patient with razuprotafib in the I-SPY COVID Trial (NCT04488081),...
News, Short Squeeze, Breakout and More Instantly...
Aerpio Pharmaceuticals Inc. Company Name:
ARPO Stock Symbol:
NASDAQ Market:
Shares of Aadi to commence trading on the Nasdaq Capital Market on August 27, 2021 under ticker symbol “AADI” Concurrent $155 million PIPE financing is backed by leading life science investors led by Acuta Capital Partners and KVP Capital and in...
3 Penny Stocks That Investors Are Eyeing Right Now With 2021 moving faster than ever, investors continue to look for the best penny stocks to buy. Although it can be challenging given the current market conditions, there are plenty of ways to find value with penny stocks . The m...